Medtronic ( (MDT)) has released its Q2 earnings. Here is a breakdown of the information Medtronic presented to its investors. Don't Miss out on Research Tools: Medtronic plc, headquartered in ...

Medtronic lifted the lower end of its annual profit forecast for a second time on Tuesday, banking on sustained demand for ...

Medtronic Q2 2025 revenue hits $8.4 billion with 5.3% YoY growth. Raised FY25 organic revenue growth guidance to 4.75%-5% ...

RBC Capital analyst Shagun Singh Chadha maintained a Buy rating on Medtronic (MDT – Research Report) yesterday and set a price target of $105.00. The company’s shares opened today at $84.73.

Medtronic has acquired Netherlands-based Fortimedix Surgical in a bid to boost its surgical and endoscopy portfolio. Fortimedix Surgical made the announcement on LinkedIn, writing: “We are ...

Medtronic plc, a global leader in healthcare technology, has today released its fiscal year 2024 Impact Report. The report ...

Medtronic (NYSE:MDT) just dropped its Q2 FY25 numbers, and it's a mixed bag. Revenue climbed 5.3% to $8.4 billion, nudging past analyst expectations. Diabetes stole the spotlight with a 12.4% ...

This has allowed Medtronic to install 22 solar arrays across ... To do that, we need to design products and packaging with their end-of-life journey in mind, whether that's reprocessing, recycling ...

The Minimax ® Hardshell Venous Reservoir is designed to support a wide range of children requiring gentle and effective blood drainage. This smaller reservoir creates reduced blood contact with a ...

The Simulus ® Adjustable Annuloplasty Ring and Band are fully flexible and enable finite adjustments. Based on preference and patient need, surgeons can choose between the Simulus Adjustable ...

The InPen with Simplera CGM. [Image courtesy of Medtronic] Medtronic (NYSE:MDT) announced today that it received FDA clearance for its new InPen insulin delivery system application. The app features ...